Company Data

Genenta Science S.p.A.

Ticker
GNTA
Current Price
$4.2 -2.33%
Market Cap
$76.8M
Price Target
Refer to Report
Volume
511
52wk Range
$2.79 - $7.28
Advanced Market Data

Overview

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company’s product under development includes Temferon – a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy